3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Melanoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Kidney Neoplasms
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
Bevacizumab
37
Paclitaxel
33
Carboplatin
25
pembrolizumab
23
Specimen Handling
21
olaparib
19
Magnetic Resonance Spectroscopy
19
Gemcitabine
18
liposomal doxorubicin
16
Cyclophosphamide
16
fludarabine
12
Topotecan
12
Biopsy
12
niraparib
11
Cisplatin
10
Fulvestrant
9
Taxes
8
Nivolumab
8
Immunoglobulin G
8
Disulfides
8
Doxorubicin
7
palbociclib
6
aldesleukin
6
Surveys and Questionnaires
6
Oxaliplatin
5
Letrozole
5
Fluorouracil
5
trastuzumab deruxtecan
4
oregovomab
4
mirvetuximab soravtansine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Biopsy, Large-Core Needle
×
90 days
×
Clear all
No trials found.